The numbers didn't lie.

Ethan had learned this early — in his first life, in the second year of his residency, when a supervising physician had told him that the body was fundamentally honest, that it communicated in gradients and rates and response curves, and that a clinician's job was to learn to read that language fluently. The body doesn't perform. It doesn't have an agenda. It tells you exactly what is happening, if you know how to ask.

He was looking at the numbers now.

Twelve weeks of Tuesday sessions, annotated in his careful shorthand. Scarring reduction rate: 12%, then 19%, then 26%, then — since she'd started spending more time in his vicinity in a non-clinical capacity — accelerating. The latest measurement, taken this morning, showed 34%.

Twelve percent in the first four weeks. Twenty-two percent in the eight weeks since.

The numbers didn't lie.

He put the notebook down and looked at the vial she had left on his workbench.

It was a small thing. A sealed glass container about the length of his finger, filled with a dark liquid that had the specific luminescence of high-grade mana concentrate — the kind used in combat field kits for emergency stabilization, the kind that was genuinely difficult to source because the synthesis required a practitioner with both purification and healing affinity, which was apparently a combination the world of Astraria didn't produce naturally. The label was in the neat, angular hand he'd learned to recognize as hers, with a notation he'd also learned to recognize: a date, a dosage calculation, and at the bottom, in slightly different ink as if added as an afterthought: *for the kit.*

She had found this somewhere and brought it to him. She had stayed for approximately eight minutes — delivered it, accepted his thanks in a tone that suggested she was slightly irritated by needing to be thanked at all, asked two questions about a mana flow theory he'd mentioned last Tuesday, and then left.

He had watched her go, and then he had looked at the vial, and then he had sat with an unusual quality of stillness for several minutes.

The thing was, he understood the gift. He understood it medically — the concentrate would genuinely extend his field kit's stabilization capacity by a meaningful margin, and it was difficult to source, and she had sourced it. That part made sense. That part he could hold in the clinical framework without difficulty.

What he couldn't easily categorize was the *for the kit.*

Two words. Added in different ink. The visible evidence of someone who had written a thing and then decided to give it a label that made it safe, professional, within parameters. He was familiar with that impulse. He used it himself regularly. He had entire notebooks full of it.

He wrote: *Subject brought a field concentrate — high-grade, difficult to source. Stated purpose: supplementary kit material. Accurate but incomplete description of function. Note: subject is beginning to make gestures that do not fit easily into the dependency-maintenance framework. Gestures for which the clinical language is insufficient.*

He paused.

He added: *This is worth paying attention to.*

He capped the pen and picked up the vial, turning it in the afternoon light, watching the luminescence shift. She had measured the dosage herself, he noticed. It was calibrated to his estimated output level, which meant she had been paying attention to his output levels. Which meant she was doing her own tracking, in parallel with his.

Two people keeping separate records of the same phenomenon. He thought about what that meant.

The door opened.

She arrived exactly at the usual time, with the usual economy of movement, wearing the training clothes she used when she came directly from the early session rather than the administrative dress she wore when she had time to change. She was carrying her assessment folder and she set it on the table without ceremony and sat in the chair.

"The concentrate," she said. Not a question.

"The concentrate," he agreed. "Thank you. The dosage calculation is precise."

She looked at the folder. "I had access to the supply records. It wasn't difficult."

He didn't say that the synthesis wasn't what he was thanking her for. He had learned that she received gratitude better when it was specific and brief, and that pressing further produced diminishing returns.

He set his hands out and she placed her wrist across them, and he settled into the assessment with the quiet efficiency they had both developed over twelve weeks of Tuesday mornings — finding the pulse, tracking the channels, letting the current come in at the calibrated level that worked best for this stage of the treatment.

The channels felt different today. Not dramatically — nothing in this process was dramatic, everything was incremental, everything was patient — but different in a specific, measurable way. The resistance in the primary scarring was less. Not just less than the beginning of treatment; less than last week. He followed the thread of the current deeper into the secondary branching, checking the rate of change against his mental map of where things had been.

"The secondary branching," he said, after a few minutes.

She looked up from the folder she'd been reviewing while he worked. "What about it?"

"It's responding faster." He adjusted his approach, threading the current more specifically, testing the depth of the clearance. "The primary channels are clearing faster than projected, which means the deposits are being addressed at the source rather than just managed at the surface. The secondaries are showing the same pattern, earlier than I expected."

A pause.

"How much faster," she said.

"Significantly." He moved through the assessment methodically, mapping the change against his numbers. "The rate since two weeks ago has nearly doubled. I'm trying to identify what changed."

The silence in the room had a particular quality. He was aware of it — the specific texture of a quiet that holds something neither person is addressing directly. He had learned to read that quality over twelve weeks too. It was part of the data.

"The exposure duration," she said, neutrally. "I've been in your vicinity more. Outside the formal sessions."

"Yes," he agreed. "That's the variable I'd already identified." He kept his voice even, clinical, because that was the register they both operated most comfortably in and because the clinical register was honest without being pressuring. "The passive effect appears to compound with sustained contact. The formal sessions address the acute deposits. The passive exposure may be addressing the underlying environment that produces them."

"So the treatment is more effective when I'm—" She stopped.

"Around," he said.

"Around," she echoed.

He finished the assessment and released her wrist. The current settled back to its pilot-light state with the reluctance he'd stopped pretending not to notice. He picked up his pen and made the relevant notations.

"The number," she said. She was looking at his notebook, not asking to read it, just — asking.

He turned it so she could see the figure.

34%.

She looked at it for a long time. Long enough that he did not interrupt, because some things needed whatever time they needed, and he had learned when to be patient.

"The end of term," she said finally. "You said end of term was conservative."

"It was conservative," he said. "At the current rate, the primary channels could be at baseline in six to eight weeks. Possibly five."

She absorbed this. He watched, from the careful peripheral angle he used for observation, the way the controlled surface of her face held something underneath it that was not quite what it usually held — larger than usual, more complicated, the specific weight of a person who has been managing the absence of hope for a long time and is being asked to consider whether that absence is permanent.

"The secondary channels," she said.

"Will need more time. But if the primary clears, the secondary deposits stop being fed. The process becomes self-sustaining." He paused. "Kaelen."

She looked up.

He had been thinking about how to say the next thing. He'd been thinking about it since he'd run the numbers this morning and understood what they meant — not just medically but in the larger sense, in the sense of what it meant for a person who had arranged her entire life around an inevitability that was becoming less inevitable by the week.

"The numbers are telling me something," he said. "I'd rather you heard it from me directly than had to ask: what I'm seeing in the assessment today suggests that a full recovery of the primary channels is a realistic outcome. Not a hoped-for one. A realistic one. Within the current treatment trajectory."

The room was very quiet.

"You're not just managing it," he said. "I think we're actually fixing it."

She looked at the table. Her hands were still; she had very controlled hands, usually, but even the stillness had a quality to it now that was different — not the stillness of management but of something that had stopped bracing.

"I'm not going to say it," she said. Her voice was steady. "Not until the primary is confirmed."

"That's reasonable," he said.

"I have been—" She stopped. Started differently. "I've been managing a set of expectations for six years. I would prefer not to revise them prematurely."

"I understand that," he said. He did understand it. He understood it in the specific way of someone who had learned to hold expectations at arm's length as a protective measure, and who knew how disorienting it was when the distance started to collapse.

"If the trajectory holds," she said, "and the primary channels clear — what happens to the treatment cadence?"

"Reduces. Monthly, then as-needed. The formal sessions wouldn't be necessary at the same frequency."

A silence.

"The passive exposure," she said.

"Harder to quantify," he said. "But based on the data, sustained proximity appears to be a significant variable in the rate. If that variable were removed—" He considered the sentence. "I don't yet know what the maintenance baseline would look like without it. I'd want to study that before recommending any changes."

She was quiet for a long time, looking at the assessment folder, and he let her be quiet.

"The passive radius," she said finally. "Five hundred meters. You've mapped it."

"Approximately."

"The administrative wing is four hundred and eighty meters from the east quadrant residential building."

He looked at her.

"I measured it," she said, with the tone of someone offering a piece of data that was also, possibly, something else entirely.

He thought about that for a moment — a commander of the Royal Guard measuring a distance between her office and a student's dormitory, and keeping that number, and being willing to say it out loud in a clinical context.

"That's good to know," he said.

She stood, picked up the folder, smoothed her uniform with the gesture that meant she was returning to her surfaces. She walked to the door and stopped.

"Ethan," she said, her back to him.

He was still.

"The concentrate. I want to be clear about something." A pause. "I brought it because I wanted to. Not because the kit needed it, though it does. I wanted to, and I found a way to frame it that I could actually do." She didn't turn around. "I thought you should have the accurate version."

He held the moment carefully.

"Thank you," he said. "For the accurate version."

She left.

He sat in the annex for a long time afterward, with the notebook and the vial and the numbers that told him things he was almost ready to say out loud, and he thought about a woman who had found a way to give him something true by wrapping it in a practical frame, and about what it meant that she had then unwrapped it.

He thought: she is learning to say the thing.

He thought: so am I.

He wrote in the notebook, in the smaller handwriting he used for things he wasn't ready to classify yet: *The gift was not about the kit. The measurement was not about the passive effect. I am beginning to understand what these things are actually about, and the clinical framework is becoming inadequate.*

He looked at what he'd written.

He did not cross it out.

Outside, the afternoon campus moved through its routines, and somewhere in the east wing the announcement board was updating the week's schedule, and near the bottom of it, in the administrative typeface that had never seemed particularly significant before, was a new entry: *Vanguard Elite Recruitment Delegation — Arrival: Thursday. Delegation Commander: Freya Drake.*

He read it on the way back to his room.

He filed it.

He went to dinner, and the bird was on the windowsill when he returned, and the evening was good, and he sat with the notebook and the numbers and the particular quality of knowing something was beginning that he didn't yet have the full vocabulary for, and he did not rush to find the words.

They would come when they were ready.

The numbers, at least, were clear.

Thursday came with the clarity of something that had been scheduled.

He had been prepared, in the abstract, for the arrival of a Vanguard delegation — he'd processed the announcement board notice with the same methodical attention he gave to everything, noted the timing, considered the implications for his schedule, and moved on. What he had not fully prepared for was the physical reality of Commander Freya Drake's arrival, which turned out to be categorically different from the announcement.

She arrived by air.

He was crossing the south quadrant when the sound reached him first — a deep displacement of air, the bass-register concussion of something very large descending — and then the shadow crossed the courtyard, and then the dragon landed on the stone twenty meters ahead of him with the specific casualness of a creature that had been landing on things its entire life and considered the act beneath commentary.

The dragon was enormous. He had known, intellectually, that Dragon-kin could take full forms — the dead boy's memories had supplied this fact without much emotional weight attached to it — but the intellectual knowledge and the embodied experience of standing in the shadow of something that size were different quantities. He made an automatic note of the wingspread, the scale pattern, the specific amber-gold of the eyes, and the way the surrounding mana field reorganized itself around the creature's presence.

Then the dragon folded down, in the practiced fluid motion of a large body accustomed to inhabiting smaller spaces, and the woman standing in its place was almost jarringly human-scale.

Almost. She was taller than average, broad-shouldered in the way of someone who had been building muscle since childhood, with the particular quality of stillness that belonged to people who were rarely the least dangerous thing in any room. The scales that traced her cheekbones and jaw — iridescent copper-gold, catching the morning light in a way that suggested they were not entirely decorative — shifted slightly as she scanned the courtyard. Her eyes, when they found him, were the same amber as the dragon's.

She looked at him for approximately three seconds.

He looked back, the way he looked at everything: openly, without performing either intimidation or deference, cataloguing what he observed.

She crossed the courtyard. He waited, because she was clearly moving toward him and he had nowhere urgent to be.

"Solvane," she said. Not a question — she'd done research.

"Commander Drake," he said. "Welcome to Aegis Academy."

She stopped at a distance that most people would have considered slightly too close, studying him with the directness of someone who had never had any reason to learn social circumspection. Her nostrils flared — very slightly, quickly controlled — and something shifted in her expression in a way he filed immediately as interesting.

"You're smaller than I expected," she said.

"That's medically accurate," he agreed. "I have data on my exact measurements if that would be useful."

A silence. She looked at him the way he imagined creatures with very good threat-assessment instincts looked at things they had not yet categorized. Then: "You're not afraid of me."

"No," he said. "Should I be?"

"Most people are."

"Most people probably have good reasons," he said. "I haven't identified mine yet."

Something crossed her face — not a smile exactly, but the ghost of one, the specific expression of a person who has encountered an unexpected response and is recalibrating. She looked at him for another moment, and he felt the passive current doing something particular in her vicinity — not the gradient response it produced near Kaelen, which was oriented and specific, but something more like the heightened readiness it showed when something significant was in the nearby environment.

He noted this. He did not name it yet.

"I've been asked to evaluate the Combat Medic program," she said. "Your name came up."

"I'd imagine it did," he said. "I'm the only student enrolled."

The ghost of a smile again. "Tomorrow. Sixth hour. Vanguard training grounds."

"I'll be there," he said.

She held his gaze for one more beat — long enough to be deliberate — and then turned and walked toward the administrative building with the economy of movement of someone who did not waste energy on anything that wasn't directional.

He watched her go, and the current settled back to its normal register, and he made his notes.

*Commander Freya Drake — Dragon-kin, Vanguard Elite. First contact: south quadrant. Observation: unusual mana displacement in her vicinity, different in character from anything previously documented. Passive effect response: heightened, non-gradient. Unclear mechanism. Query: is this a Dragon-kin-specific phenomenon, or something else? Further data required.*

He considered the page.

He wrote: *She looked at me the way the bird did, the first morning. Not like a threat. Like something she was deciding about.*

He closed the notebook.

The evening's announcement board update, which he checked as a matter of routine, had a new entry in the personnel column: Commander Drake's delegation would be extending their visit by one week, pending completion of the full program evaluation.

He filed this and went to bed.

In the morning, he would find out what a Vanguard evaluation looked like.

In the morning, several things would become clearer.